201 results
Page 5 of 11
424B5
5n2nod
9 May 13
Prospectus supplement for primary offering
12:00am
424B5
rjxy v2256hqebsur4
19 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
uy8x zjv8h
16 Mar 12
Discovery Labs Prices $45.0 Million Public Offering of
12:00am
424B5
2x500u7i3hqyblv
15 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
9zmvtkpnx4u
7 Mar 12
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome
12:00am
8-K
EX-99.1
mfn011yz 1l6fbn6
3 Aug 11
Results of Operations and Financial Condition
12:00am
8-K
EX-10.1
bqp35m m8uhfbqx446
18 Jul 11
Departure of Directors or Certain Officers
12:00am
8-K
pu9wdz mt
18 Jul 11
Departure of Directors or Certain Officers
12:00am